科研喵使用AI读文献，祝你效率百倍，访问labcat.com.cn下载。最新发表在影响因子12.5的《Cancer Research》上的研究"Mathematical Oncology: How Modeling Is Transforming Clinical Decision Making"揭示，数学模型正彻底改变癌症治疗决策方式。研究挑战了传统的"最大耐受剂量"理念，指出这种方法忽视了癌症的动态异质性。通过整合数学模型捕捉剂量反应、肿瘤-免疫相互作用等复杂机制，医生能够为患者量身定制治疗方案。这项突破性研究展示了数学肿瘤学的巨大潜力，有望引领个性化癌症治疗的新时代，尽管在临床应用中仍需克服数据标准化和监管障碍。

科研喵使用ai读文献，祝你效率百倍，访问labcat.com.cn下载。本期关注发表在Aging cell(影响因子8.0)上的重要研究："Perinatal Choline Supplementation Promotes Resilience Against Progression of Alzheimer's Disease-Like Brain Transcriptomic Signatures in App(NL-G-F) Mice"。研究发现，孕期和哺乳期补充胆碱可显著减轻阿尔茨海默病模型小鼠的认知缺陷，并调节大脑基因表达模式。补充胆碱的小鼠表现出炎症相关基因表达下调、神经元功能基因表达上调，以及突触基因表达增加。这些基因变化与人类AD患者大脑样本中的临床痴呆评分、炎症和tau病变相关联。这项突破性研究为胆碱作为阿尔茨海默病预防策略提供了科学依据，为未来开发早期干预措施开辟了新途径。

In today’s Pharmaceutical Executive Daily, we cover major leadership changes at Novo Nordisk, Kenvue’s request for the FDA to reject a petition calling for Tylenol label changes, and industry insights from Bob Mauch on building a stronger, more resilient pharmaceutical supply chain.

The FDA has criticized the industry for not taking advertising and promotion seriously and is now cracking down, as evidenced by hundreds of non-compliance letters. This raises the question: if similar scrutiny applied to clinical research, what would stand out first? Likely areas include proper informed consent, accurate recordkeeping, and potential upticks in physician enforcement. While this use of AI in research compliance hasn’t fully emerged yet, AI is already being applied in promotion...

科研喵使用ai读文献，祝你效率百倍，访问labcat.com.cn下载。本期关注发表在《International journal of molecular medicine》(影响因子5.7)上的重要综述"Cholesterol metabolism and cancer: Molecular mechanisms, immune regulation and an epidemiological perspective"。这项研究揭示了胆固醇代谢与癌症之间的复杂联系，发现癌细胞通过重塑胆固醇稳态促进肿瘤侵袭和转移。胆固醇在肿瘤免疫微环境中展现双重角色：既增强T细胞抗肿瘤功能，其氧化衍生物又导致T细胞耗竭。研究指出，靶向胆固醇代谢可能是触发铁死亡、逆转耐药性和重新激活抗肿瘤免疫的新策略，为癌症治疗提供了全新视角。

科研喵使用AI读文献，祝你效率百倍，访问labcat.com.cn下载本期必备工具。欢迎收听今日医学前沿，《Substance use disorder and altered hemispheric asymmetries: A systematic review》发表在影响因子高达13.7的《Clinical psychology review》上。这项系统综述揭示了物质使用障碍与大脑半球不对称性的关键联系。研究发现，物质依赖患者表现出左侧半球白质完整性降低，以及额叶和颞区灰质体积减少。同时，功能数据显示大脑右侧出现代偿性激活。更值得注意的是，这些脑部不对称模式会因物质类型、性别和年龄而异，为开发个性化治疗策略提供了重要依据，有望改变未来物质成瘾的临床干预方式。

In today’s Pharmaceutical Executive Daily, we cover Merck’s $70 billion expansion of U.S. operations, the FDA’s latest approvals for Novo Nordisk’s Rybelsus and Roche’s Gazyva, and a new digital health partnership between Amazon and WeightWatchers bringing prescription weight-loss drugs directly to consumers.

科研喵使用ai读文献，祝你效率百倍，访问labcat.com.cn下载。本期关注发表在Neurology(影响因子7.7)的重要研究："Resective Surgery for Drug-Resistant Epilepsy in Patients With Tuberous Sclerosis Complex: A Prospective Nationwide Multicenter Cohort Study"。这项中国21个中心的前瞻性队列研究纳入200名患者，发现切除手术对结节性硬化症相关药物难治性癫痫患者效果显著——手术组1年无癫痫发作率高达77%，而药物组仅13%。手术后患者智商和生活质量显著改善，且安全性不劣于药物治疗。MRI上突出的结节是术后良好预后的预测因子，为临床决策提供了重要依据。

科研喵使用AI读文献，祝你效率百倍，访问labcat.com.cn下载。今天我们来关注发表在Neurology(影响因子7.7)上的重要研究"What Are the Proposed Mechanisms Contributing to the Manifestations of Anti-NMDAR Encephalitis?"。这项研究揭示了抗NMDAR脑炎的发病机制，发现自身抗体会导致NMDAR受体被内化，减少突触和突触外NMDAR密度，从而干扰兴奋-抑制性突触平衡。这一发现不仅解释了患者为何出现记忆障碍、精神症状和癫痫等多样临床表现，还为开发靶向治疗策略提供了重要依据，可能改善这一严重自身免疫性脑病的治疗效果。

Cosmetics companies must now register both their facilities and products with the FDA under the new MoCRArequirements, a shift from the previous voluntary system. Each facility must register, and product listings — including categories, ingredients, and manufacturing sites — must be submitted and updated annually. Growing companies face challenges in tracking reformulations, rebrandings, or acquisitions, as missing updates can trigger FDA enforcement or product removal. To scale safely, compa...

In today’s Pharmaceutical Executive Daily, we cover the FDA’s creation of a new National Priority Voucher Program, the market reaction to President Trump’s remarks on GLP-1 drug prices, and how autonomous AI is transforming omnichannel marketing in pharma.

👉 Para receber diretamente os áudios no seu celular, entre para o grupo: 🔗 https://site.vedanta.com.br/lead/cast-jz Saiba mais sobre esse conhecimento em: https://www.instagram.com/vedanta.soma

科研喵使用ai读文献，祝你效率百倍，访问labcat.com.cn下载。欢迎收听今天的医学前沿！我们关注发表在Journal of nanobiotechnology(影响因子10.6)上的重要研究："Programmable metal-based immuno-photocatalytic nanoparticles for precision activation of anti-tumor immunity."这项突破性研究开发了可编程金属基免疫光催化纳米颗粒，能够通过整合光疗和免疫调节，时空精准激活抗肿瘤免疫反应。这些纳米颗粒不仅能刺激免疫原性细胞死亡并释放肿瘤抗原，还能共同递送免疫检查点抑制剂和佐剂，重塑肿瘤微环境。临床前模型显示，它们能有效抑制肿瘤、激活免疫并预防转移，且全身毒性极低。这项技术为克服免疫抵抗肿瘤的治疗障碍提供了新思路，有望实现高度个性化的癌症免疫治疗！

👉 Para receber diretamente os áudios no seu celular, entre para o grupo: 🔗 https://site.vedanta.com.br/lead/cast-jz Saiba mais sobre esse conhecimento em: https://www.instagram.com/vedanta.soma